Kura Oncology, Inc.

KURA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$74-$66-$57-$19
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$11$7$8$9
Change in WC-$44$36-$20$282
Other Non-Cash$27-$6-$3-$3
Operating Cash Flow-$81-$29-$72$269
Investing Activities
PP&E Inv.-$3-$1-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$269-$241
Inv. Sales/Matur.$0$0$168$146
Other Inv. Act.$97$60$0$0
Investing Cash Flow$94$59-$101-$95
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0-$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$1$0$1
Financing Cash Flow$0$1$0$1
Forex Effect$0$0$0$0
Net Chg. in Cash$13$31-$173$175
Supplemental Information
Beg. Cash$82$51$224$49
End Cash$95$82$51$224
Free Cash Flow-$83-$30-$72$269
Kura Oncology, Inc. (KURA) Financial Statements & Key Stats | AlphaPilot